320 related articles for article (PubMed ID: 18177480)
1. In vitro anti-oxidant and DNA protective effects of the novel 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor rosuvastatin.
Ajith TA; Riji T; Anu V
Clin Exp Pharmacol Physiol; 2008 May; 35(5-6):625-9. PubMed ID: 18177480
[TBL] [Abstract][Full Text] [Related]
2. The protective effect of rosuvastatin in human umbilical endothelial cells exposed to constant or intermittent high glucose.
Piconi L; Corgnali M; Da Ros R; Assaloni R; Piliego T; Ceriello A
J Diabetes Complications; 2008; 22(1):38-45. PubMed ID: 18191076
[TBL] [Abstract][Full Text] [Related]
3. Rosuvastatin ameliorates high-fat and high-cholesterol diet-induced nonalcoholic steatohepatitis in rats.
Okada Y; Yamaguchi K; Nakajima T; Nishikawa T; Jo M; Mitsumoto Y; Kimura H; Nishimura T; Tochiki N; Yasui K; Mitsuyoshi H; Minami M; Kagawa K; Okanoue T; Itoh Y
Liver Int; 2013 Feb; 33(2):301-11. PubMed ID: 23295058
[TBL] [Abstract][Full Text] [Related]
4. Antimutagenic and anti-oxidant activities of the non-steroidal anti-inflammatory drug celecoxib.
Ajith T; Subin JP; Jacob J; Sanjay PS; Babitha NV
Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):888-93. PubMed ID: 16173952
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of Rumex patientia (English Spinach) roots on ferric nitrilotriacetate (Fe-NTA) induced hepatic oxidative stress and tumor promotion response.
Lone IA; Kaur G; Athar M; Alam MS
Food Chem Toxicol; 2007 Oct; 45(10):1821-9. PubMed ID: 17517459
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Azadirachta indica leaf fractions for in vitro antioxidant potential and protective effects against H2O2-induced oxidative damage to pBR322 DNA and red blood cells.
Manikandan P; Anandan R; Nagini S
J Agric Food Chem; 2009 Aug; 57(15):6990-6. PubMed ID: 19583256
[TBL] [Abstract][Full Text] [Related]
7. In vitro curcumin modulates ferric nitrilotriacetate (Fe-NTA) and hydrogen peroxide (H2O2)-induced peroxidation of microsomal membrane lipids and DNA damage.
Iqbal M; Okazaki Y; Okada S
Teratog Carcinog Mutagen; 2003; Suppl 1():151-60. PubMed ID: 12616605
[TBL] [Abstract][Full Text] [Related]
8. Rosuvastatin protects against oxidative stress and DNA damage in vitro via upregulation of glutathione synthesis.
Schupp N; Schmid U; Heidland A; Stopper H
Atherosclerosis; 2008 Aug; 199(2):278-87. PubMed ID: 18154958
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of kahweol and cafestol against hydrogen peroxide-induced oxidative stress and DNA damage.
Lee KJ; Jeong HG
Toxicol Lett; 2007 Sep; 173(2):80-7. PubMed ID: 17689207
[TBL] [Abstract][Full Text] [Related]
10. Rosuvastatin protects against angiotensin II-induced renal injury in a dose-dependent fashion.
Park JK; Mervaala EM; Muller DN; Menne J; Fiebeler A; Luft FC; Haller H
J Hypertens; 2009 Mar; 27(3):599-605. PubMed ID: 19262227
[TBL] [Abstract][Full Text] [Related]
11. Blockade of geranylgeranylation by rosuvastatin upregulates eNOS expression in human venous endothelial cells.
Landsberger M; Jantzen F; Könemann S; Felix SB
Biochem Biophys Res Commun; 2005 Nov; 336(4):1005-9. PubMed ID: 16165089
[TBL] [Abstract][Full Text] [Related]
12. Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics.
Ho RH; Tirona RG; Leake BF; Glaeser H; Lee W; Lemke CJ; Wang Y; Kim RB
Gastroenterology; 2006 May; 130(6):1793-806. PubMed ID: 16697742
[TBL] [Abstract][Full Text] [Related]
13. Effect of rosuvastatin on cholestasis-induced hepatic injury in rat livers.
Awad AS; Kamel R
J Biochem Mol Toxicol; 2010; 24(2):89-94. PubMed ID: 20146376
[TBL] [Abstract][Full Text] [Related]
14. Rosuvastatin attenuates monocyte-endothelial cell interactions and vascular free radical production in hypercholesterolemic mice.
Li W; Asagami T; Matsushita H; Lee KH; Tsao PS
J Pharmacol Exp Ther; 2005 May; 313(2):557-62. PubMed ID: 15665143
[TBL] [Abstract][Full Text] [Related]
15. Insulin resistance, oxidative stress, and podocyte injury: role of rosuvastatin modulation of filtration barrier injury.
Whaley-Connell A; DeMarco VG; Lastra G; Manrique C; Nistala R; Cooper SA; Westerly B; Hayden MR; Wiedmeyer C; Wei Y; Sowers JR
Am J Nephrol; 2008; 28(1):67-75. PubMed ID: 17914247
[TBL] [Abstract][Full Text] [Related]
16. Rapid response to lipids profile and leukocyte gene expression after rosuvastatin administration in Chinese healthy volunteers.
Hua CX; Li YS; Liu YQ; Liu H; Li N; Wu Y; Xu L; Huang YL
Chin Med J (Engl); 2008 Jul; 121(13):1215-9. PubMed ID: 18710642
[TBL] [Abstract][Full Text] [Related]
17. Statins: 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibitors demonstrate anti-atherosclerotic character due to their antioxidant capacity.
Puttananjaiah MK; Dhale MA; Gaonkar V; Keni S
Appl Biochem Biotechnol; 2011 Jan; 163(2):215-22. PubMed ID: 20640529
[TBL] [Abstract][Full Text] [Related]
18. Rosuvastatin, but not simvastatin, provides end-organ protection in stroke-prone rats by antiinflammatory effects.
Sironi L; Gianazza E; Gelosa P; Guerrini U; Nobili E; Gianella A; Cremonesi B; Paoletti R; Tremoli E
Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):598-603. PubMed ID: 15681303
[TBL] [Abstract][Full Text] [Related]
19. Effect of long-term dietary administration of oregano on the alleviation of carbon tetrachloride-induced oxidative stress in rats.
Botsoglou NA; Taitzoglou IA; Botsoglou E; Lavrentiadou SN; Kokoli AN; Roubies N
J Agric Food Chem; 2008 Aug; 56(15):6287-93. PubMed ID: 18605733
[TBL] [Abstract][Full Text] [Related]
20. The effect of rosuvastatin treatment on the mean platelet volume in patients with uncontrolled primary dyslipidemia with hypolipidemic diet treatment.
Coban E; Afacan B
Platelets; 2008 Mar; 19(2):111-4. PubMed ID: 17852772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
